Milpitas, California-based Bigfoot Biomedical Inc. had already raised $37m in a Series B financing round in December 2017. The firm has now closed the round after raising another $18m, including funds from Abbott Laboratories Inc. as a first-time investor, along with other new and existing investors.
"We are excited to welcome Abbott to our list of investors," Jeffrey Brewer, president and CEO of Bigfoot Biomedical said....







